1、CANON ANNUAL REPORT 2022Fiscal Year Ended December 31,2022CANON ANNUAL REPORT 2022Strategy 1 Financial Highlights 2 To Our Shareholders 9 Business StrategyBusiness Segment/Corporate Structure 18 At a Glance 20 Research&Development 22 Production 24 Sales&Marketing 26 ESGFinancial Section 36 Financial

2、 Overview 54 Ten-Year Financial Summary 56 Consolidated Balance Sheets 57 Consolidated Statements of Income 57 Consolidated Statements of Comprehensive Income 58 Consolidated Statements of Equity 59 Consolidated Statements of Cash Flows 60 Notes to Consolidated Financial Statements 96 Schedule II Va

3、luation and Qualifying Accounts 97 Managements Report on Internal Control Over Financial Reporting 98 Report of Independent Registered Public Accounting FirmCorporate Data 103 Transfer and Registrars Office 103 Shareholder Information 103 Major Consolidated SubsidiariesCover Photo:An X-ray CT system

4、 equipped with a photon-counting detector(PCCT)system has been installed at the National Cancer Center(NCC)Exploratory Oncology Research&Clinical Trial Center in Japan,where it is currently used to conduct research exploring the clinical applications of PCCT.In the future,Canon will explore the new

5、value offered by PCCT in a wide range of clinical fields,with the aim of promoting its rapid practical application.TABLE OF CONTENTSNet Income Attributable to Canon Inc.(Billions of yen)ROE/ROA(%)2018201920202021Net Income Attributable to Canon Inc.Shareholders per Share(Yen)Net Sales(Billions of ye

6、n)Basic DilutedROE ROA20182019202020211,5004,5003,0002022010030020020222018201920202021010030020020182019202020212022024106820220Notes:1.Canons consolidated financial statements are prepared in accordance with U.S.generally accepted accounting principles.2.U.S.dollar amounts are translated from yen